Evidence map›Paper›PMID 36098249›Full record

ArticleInfluenza and other respiratory viruses2022

A novel household-based patient outreach pilot program to boost late-season influenza vaccination rates during the COVID-19 pandemic.

Lloyd Fisher, Matthew M Loiacono, Nick Payne, Tina Kelley, Michael Greenberg, Mary Charpentier, Candace Leblanc, Devi Sundaresan, Tim Bancroft, Andrea Steffens and 1 more

Open access · goldAbstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Lloyd FisherReliant Medical Group, Worcester, Massachusetts, USA.
Matthew M LoiaconoSanofi, Swiftwater, Pennsylvania, USA.ORCID 0000-0001-8100-465X
Nick PayneOptum Life Sciences, Eden Prairie, Minnesota, USA.
Tina KelleyOptum Life Sciences, Eden Prairie, Minnesota, USA.
Michael GreenbergSanofi, Swiftwater, Pennsylvania, USA.
Mary CharpentierReliant Medical Group, Worcester, Massachusetts, USA.
Candace LeblancReliant Medical Group, Worcester, Massachusetts, USA.
Devi SundaresanReliant Medical Group, Worcester, Massachusetts, USA.
Tim BancroftOptum Life Sciences, Eden Prairie, Minnesota, USA.
Andrea SteffensOptum Life Sciences, Eden Prairie, Minnesota, USA.ORCID 0000-0001-8883-2001
Misti PaudelOptum Life Sciences, Eden Prairie, Minnesota, USA.
Optum (United States) · USReliant Medical Group · USSanofi (United States) · USUniversity of Massachusetts Chan Medical School · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe objective of this study was to test a novel household-based approach to improve late-season influenza vaccine uptake during the 2020-2021 season, using Epic's MyChart patient portal messages and/or interactive voice response telephone calls.

methodsThis study was a non-blinded, quality improvement program using a block randomized design conducted among patients from Reliant Medical Group clinics residing in a traditional household (≥2 individuals clinically active in the Reliant system living at the same address). Households were randomized 1:1:1 into intervention arms: non-tailored communication (messaging based on CDC's seasonal influenza vaccination campaign), tailored communication (comprehensive communication including reinforcement of the importance of influenza vaccination for high-risk individuals), and standard-of-care control. Influenza vaccination during the program was captured via medical records, and the odds of vaccination among communication arms versus the control arm were assessed. A survey assessing influenza vaccination drivers was administered using MyChart.

resultsInfluenza vaccination increased by 3.3% during the program period, and no significant differences in vaccination were observed in intervention arms relative to the control arm. Study operationalization faced substantial challenges related to the concurrent COVID-19 pandemic. Compared with vaccinated survey respondents, unvaccinated respondents less frequently reported receiving a recommendation for influenza vaccination from their healthcare provider (15.8% vs. 42.3%, p < 0.001) or awareness that vaccination could protect themselves and higher risk contacts (82.3% vs. 92.6%, p < 0.001).

conclusionsNo significant effects of the interventions were observed. Survey results highlighted the importance of healthcare provider recommendations and the need for increased education around the benefits of vaccination.

Indexed as

COVID-19Influenza, HumanInfluenza VaccinesHumansPandemicsPilot ProjectsSeasonsVaccinationInfluenza Vaccinesinfluenzalate seasonvaccination

Identifiers

PMID36098249
PMCPMC9530505
OpenAlexW4295346778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.